
    
      -  Safety/ Tolerability evaluation

           -Adverse events, Physical examinations, Vital signs, ECG (including continuous ECG
           monitoring), Laboratory tests (including hematology, chemistry, coagulation, PBS,
           NAD(P)+/NAD(P)H ratio, urinalysis), CIC

        -  Pharmacokinetic Evaluation

             -  Serial blood samples and urine collections for pharmacokinetic evaluations will be
                conducted between 0 (pre-dose) and 96 hours after a single oral dose.

             -  Blood sampling time pre-dose, 1h, 2h, 3h, 4h, 6h, 8h, 10h, 12h, 16h, 24h, 36h, 48h,
                72h post-dose

             -  Urine collection time 0h - 6h, 6h - 12h, 12h - 24h, 24h - 48h, 48h - 72h

             -  Evaluation parameters AUClast, AUCinf, Cmax, Tmax, t1/2, Vd/F, CL/F, Ae, fe, CLR
    
  